Euglucon 5mg Tablets is primarily indicated in conditions like Non-insulin dependent diabetes mellitus, Softening and dilatation of cervix before mechanical cervical dilatation.
Euglucon 5mg Tablets is contraindicated in conditions like Renal failure,Liver diseases, Diabetic coma,Impaired renal function,Insulin dependent diabetes mellitus.
The severe or irreversible adverse effects of Euglucon 5mg Tablets , which give rise to further complications include Thrombocytopenia, Cholestatic jaundice, Aplastic anemia, Hemolytic anemia, Cholestatic jaundice, Aplastic anemia, Hemolytic anemia, Leucopenia, Agranulocytosis, Pancytopenia, Hemolytic anemia, Aplastic anemia. Euglucon 5mg Tablets produces potentially lifethreatening effects which include Hypersensitivity reactions, Renal failure, Hypoglycemia, Hypoglycemia, Hypoglycemia, Pneumonia. which are responsible for the discontinuation of Euglucon 5mg Tablets therapy.The signs and symptoms that are produced after the acute overdosage of Euglucon 5mg Tablets include Coma, Hypoglycemia, Cerebral damage. The symptomatic adverse reactions produced by Euglucon 5mg Tablets are more or less tolerable and if they become severe, they can be treated symptomatically, these include Nausea, Gl upset, Heart burn, Allergic skin reactions, Hepatitis, Hypoglycemia.
During treatment with Euglucon 5mg Tablets , compliance to diet and regular tablet intake are of utmost importance to preserve the efficacy of treatment and to avoid unwanted changes in the blood sugar levels. Hypoglycemic reactions may provoked by overdosage of Euglucon 5mg Tablets , interacting drugs, dietary errors (omitting meals), the signs of it being headache, irritability, restlessness, profuse sweating, insomnia, tremor, impairment of performence and alertness, such hupoglycemic episodes are nearly always promptly relieved by the intake of sugar.